Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

NCT00174239 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

220

Enrollment

INDUSTRY

Sponsor class

Stopped See Detailed Description for termination reason.

Conditions

Parkinson Disease

Interventions

DRUG: cabergoline
DRUG: controlled-release levodopa / carbidopa

Sponsor

Pfizer